A citation-based method for searching scientific literature

Mary E Ropka, Jennifer Wenzel, Elayne K Phillips, Mir Siadaty, John T Philbrick. Cancer Epidemiol Biomarkers Prev 2006
Times Cited: 112



B B Biesecker, N Ishibe, D W Hadley, T R Giambarresi, R G Kase, C Lerman, J P Struewing. Am J Med Genet 2000
Times Cited: 91




List of shared articles



Times cited

Health beliefs associated with readiness for genetic counseling among high risk breast cancer survivors.
Maija Reblin, Monica L Kasting, Kelli Nam, Courtney L Scherr, Jongphil Kim, Ram Thapa, Cathy D Meade, M Catherine Lee, Tuya Pal, Gwendolyn P Quinn,[...]. Breast J 2019
4

Anticipated health behaviour changes and perceived control in response to disclosure of genetic risk of breast and ovarian cancer: a quantitative survey study among women in the UK.
Susanne F Meisel, Lindsay Sarah Macduff Fraser, Lucy Side, Sue Gessler, Katie E J Hann, Jane Wardle, Anne Lanceley. BMJ Open 2017
8

Participation of Korean families at high risk for hereditary breast and ovarian cancer in BRCA1/2 genetic testing.
Young Sun, Eunyoung Kang, Hyunnam Baek, Jaehag Jung, Euijun Hwang, Jauk Koo, Eun-Kyu Kim, Sung-Won Kim. Jpn J Clin Oncol 2015
0

Individual and family characteristics associated with BRCA1/2 genetic testing in high-risk families.
Maria C Katapodi, Laurel L Northouse, Kara J Milliron, Guipeng Liu, Sofia D Merajver. Psychooncology 2013
14


Differences between women who pursued genetic testing for hereditary breast and ovarian cancer and their at-risk relatives who did not.
Maria C Katapodi, Laurel Northouse, Penny Pierce, Kara J Milliron, Guipeng Liu, Sofia D Merajver. Oncol Nurs Forum 2011
15